|
|
|
|
|
|
|
|
P.č. |
Č.m. |
Název |
Zkratka |
Jednotky |
Výraz |
|
1 |
1548 |
Vápník ioniz. -
výp. |
S_CaIV |
mmol/l |
(60x[S_Ca..]-0.00832x[S_PROT])/([S_PROT]+60) |
|
2 |
1549 |
Buffer base -
výp. |
S_BBS. |
mmol/l |
[S_Na..]+[S_K...]-[S_Cl...] |
|
3 |
1584 |
Močovina - odpad |
fU_UREA |
mmol/d |
[U_UREA]x[U_OBJ.]/1000 |
|
4 |
1585 |
Kreatinin - odpad |
fU_KREA |
mmol/d |
[U_KREA]x[U_OBJ.]/1000 |
|
5 |
1586 |
Kys. močová -
odpad |
fU_KMOC |
mmol/d |
[U_KMOC]x[U_OBJ.]/1000 |
|
6 |
1587 |
Sodík - odpad |
fU_Na |
mmol/d |
[U_Na..]x[U_OBJ.]/1000 |
|
7 |
1588 |
Draslík - odpad |
fU_K |
mmol/d |
[U_K...]x[U_OBJ.]/1000 |
|
8 |
1589 |
Chloridy - odpad |
fU_Cl |
mmol/d |
[U_Cl..]x[U_OBJ.]/1000 |
|
9 |
1590 |
Vápník - odpad |
fU_Ca |
mmol/d |
[U_Ca..]x[U_OBJ.]/1000 |
|
10 |
1591 |
Fosfor - odpad |
fU_P |
mmol/d |
[U_P..]x[U_OBJ.]/1000 |
|
11 |
1592 |
Hořčík - odpad |
fU_Mg |
mmol/d |
[U_Mg..]x[U_OBJ.]/1000 |
|
12 |
1593 |
Celková bílk. -
odpad |
fU_PROT |
g/d |
[U_PRO.]x[U_OBJ.]/1000 |
|
14 |
1512 |
Povrch těla |
Pt_POVR |
m2 |
0.007184x[Pt_VAHA]0.425x[Pt_VYSK]0.725 |
|
15 |
1513 |
Body mass index |
Pt_BMI |
kg/m2 |
[Pt_VAHA]/([Pt_VYSK]2x0.0001) |
|
16 |
1575 |
Clearence
kratininu |
C_KREA |
ml/s |
[U_OBJ..]x[U_KREA.]/(IF(VAL?([U_ČAS.]x3.60.86.4))/[S_KREA] |
|
17 |
1557 |
Albumin -
globulin |
S_EAGP |
pom |
[S_EALB]/([S_A1G.]+[S_A2G.]+[S_B1G..] .]+[S_B2G..]+[S_GG..]) |
|
18 |
1545 |
Osmolalita
vypočtena |
S_OSMV |
mmol/kg |
2x[S_Na..]+[S_UREA]+[S_GLU.] |
|
19 |
1544 |
Osmolalita
efektivní |
S_OSME |
mmol/kg |
2x[S_Na..]+[S_GLU.] |
|
20 |
1576 |
Clearence
korigovaná |
C_KOR |
ml/s |
[C_KREA]x1.73/[Pt_POVR] |
|
21 |
1573 |
Tubulární
resorpce |
C_RESO |
arb.j. |
[C_KREA]-([U_OBJ.])/86400)/([C_KREA]) |
|
22 |
707 |
PCR |
U_PKR |
|
((0.176x[Pt_VAHA])+([fU_UREA]/5.495))/[Pt_VAHA] |
|
23 |
1628 |
Fr. exkrece
sodíku |
Fe_Na.. |
1 |
(([U_Na..]/[S_Na..])/([U_KREA]x1000/[S_KREA])) |
|
24 |
1629 |
Fr. exkrece
draslíku |
Fe_K.. |
1 |
([U_K...]/[S_K...])/([U_KREA]x1000/[S_KREA]) |
|
25 |
1630 |
Fr. exkrece
vápníku |
Fe_Ca.. |
1 |
([U_Ca...]/[S_Ca...])/([U_KREA]x1000/[S_KREA]) |
|
26 |
1631 |
Fr. exkrece
fosforu |
Fe_P.. |
1 |
([U_P...]/[S_P...])/([U_KREA]x1000/[S_KREA]) |
|
27 |
1543 |
Saturace transf.
- výp. |
S_SATR |
výp% |
([S_Fe...]x5.58x70.9)/([S_TRNF]x100 |
|
28 |
1547 |
Index aterogenity
|
S_IA |
jedn |
(VAL([S_CHOL])-VAL([S_HDCL]))/VAL(S_HDCL])) |
|
29 |
1556 |
Poměr FPSA/PSA |
S_rPSA |
1 |
([S_fPSA]/[S_tPSA])) |
|
30 |
1581 |
Glukóza 1 - odpad |
fU_GLU1 |
mmol |
[U_GLU.]x[U_OBJ.]/1000 |
|
32 |
1574 |
Clearence urea |
C_UREA |
ml/s |
[U_OBJ.]x[U_UREA.]/86.4/[S_UREA]x0.001 |
|
33 |
1578 |
Erytrocyty -
přepočet |
fU_ERY. |
100/s |
3.3x[U_ERY.]x[U_OBJ.]/[U_ČAS] |
|
34 |
1579 |
Leukocyty -
přepočet |
fU_LEUK |
100/s |
3.3x[U_LEUK.]x[U_OBJ.]/[U_ČAS] |
|
35 |
1580 |
Válce - přepočet |
fU_VALC |
100/s |
3.3x[U_VALC]x[U_OBJ.]/[U_ČAS] |
|
37 |
1557 |
Albumin -
globulin |
S_EAGP |
pom |
[S_EALB]/([S_EA1G]+[S_EA2G]+[S_EBGL]+[S_EGGL]) |
|
38 |
1601 |
Kortizol - odpad |
fU_KOR. |
nmol/d |
[U_KOR.]x[U_OBJ.]/1000 |
|
40 |
1551 |
GF - Cystatin |
S_GFCY |
|
[S_CysC]<2.5,1.412*[S_CysC]^-1.68 |
|
41 |
1571 |
U Ca../U_KREA |
qU_CAKR |
1 |
[U_Ca..]/[U_KREA] |
|
42 |
M1 |
Registr: |
M1 |
|
515.3832*([S_KREA]^-1.154)*((VEK/365.25)^-0.203)[S_KREA]^ |
|
43 |
1550 |
GF-MDRD |
S_GFMD |
ml/s |
(SEX=1)&(VEK/365.25)>18,([M1]>=1.5,">1.5",[M1]) |
|
44 |
1550 |
GF-MDRD |
S_GFMD |
ml/s |
(SEX=2)&(VEK/365.25)>18,([M1]*0.742)>1.5,">1.5",([M1]*0.742) |
|
46 |
1568 |
Bílkovina/kreatinin |
U_PCR |
mg/mmol |
[U_PRO.]*1000/[U_KREA] |
|
1567 |
Albumin/Kreatinin |
U_ACR |
g/mol |
[U_ALB]/[U_KREA] |
|
|
49 |
M4 |
Registr: |
M4 |
|
[Pt_VYSK]*0.81/[S_KREA] |
|
50 |
M5 |
Registr: |
M5 |
|
[Pt_VYSK]*0.959/[S_KREA] |
|
51 |
M3 |
Registr: |
M3 |
|
[Pt_VYSK]*0.663/[S_KREA] |
|
52 |
1550 |
GF-MDRD |
S_GFMD |
ml/s |
(SEX=1)&(VEK/365.25)>1&VEK/365.25<=12,[M4]>1.5,">1.5",[Pt_VYSK]*0.810/[S_KREA] |
|
53 |
1550 |
GF-MDRD |
S_GFMD |
ml/s |
(SEX=1)&(VEK/365.25)>12&VEK/365.25<18,[M5]>1.5,">1.5",[Pt_VYSK]*0.959/[S_KREA] |
|
54 |
1550 |
GF-MDRD |
S_GFMD |
ml/s |
(VEK/365.25)<1,[M3]>1.5,">1.5",[M3] |
|
55 |
1550 |
GF-MDRD |
S_GFMD |
ml/s |
(VEK/365.25)>1&(SEX=2)&(VEK/365.25)<=18,[M4]>1.5,">1.5",[M4] |
|
56 |
142 |
Androgenní
index-FAI |
S_FAI |
% |
[S_TRTR]/[S_SHBG]*100 |
|
57 |
1563 |
GF – CKD-EPI |
S_CKD-EPI |
ml/s/1,73 m2 |
2.4*([S_KREA]/61.9)^-0.329
*0.993^(Patient.Age/365.25) pro (Patient.Sex="F") a [S_KREA]<=
62 |
|
58 |
1563 |
GF – CKD-EPI |
S_CKD-EPI |
ml/s/1,73 m2 |
2.4*([S_KREA]/61.9)^-1.209 *0.993^(Patient.Age/365.25)
pro Patient.Sex="F" a [S_KREA]> 62 |
|
59 |
1563 |
GF – CKD-EPI |
S_CKD-EPI |
ml/s/1,73 m2 |
2.35*([S_KREA]/79.6)^-0.411
*0.993^(Patient.Age/365.25) pro (Patient.Sex="M" a [S_KREA]<= 80 |
|
60 |
1563 |
GF – CKD-EPI |
S_CKD-EPI |
ml/s/1,73 m2 |
2.35*([S_KREA]/79.6)^-1.209
*0.993^(Patient.Age/365.25) pro (Patient.Sex="M" a [S_KREA]> 80 |
|
61 |
97 |
CDT% |
S_CDT |
% |
([S_CDTmg/l]/
*([S_TRFN]/)*0.1 |
|
62 |
1625 |
Cholesterol
non-HDL |
nHDLC |
mmol/l |
[S_Chol] -
[S_Chol HDL] |
aktualizováno 3/2024